Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS32582 in moderate to severe plaque psoriasis (MECAP)
NCT07129382Phase 2Recruiting
- Sponsor
- Akeso, Inc.
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CS32582 in plaque psoriasis, sponsored by Akeso, Inc.. Started Sep 2025; status: recruiting.
02
Drugs
CS32582
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07129382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07129382.